Kumar, Raju and Kotapalli, V. and Naz, Ashmala and Gowrishankar, S. and Rao, S. and Pollack, J.R. and Bashyam, M.D. (2018) XPNPEP3 is a novel transcriptional target of canonical Wnt/β-catenin signalling. Genes, Chromosomes and Cancer, 57 (6). pp. 304-310. ISSN 1045-2257

Text Genes Chromosomes Canc 57 p304.pdf Restricted to Repository staff only Download (821Kb) | Request a copy

Abstract

Canonical Wnt/β-catenin signaling plays important roles in embryonic development and adult tissue regeneration while aberrant Wnt activation is the major driver of sporadic colorectal cancer (CRC). Thus, it is important to characterize the complete β-catenin target transcriptome. We previously performed microarray-based mRNA profiling of rectal cancer samples stratified for Wnt status. In addition to AXIN2 and EPHB2, XPNPEP3 transcripts were significantly elevated in tumors exhibiting activated Wnt/β-catenin signaling, validated by Q-PCR. Three different cell lines supported elevated XPNPEP3 transcript levels upon activation of Wnt signaling, confirmed using promoter-luciferase assays. Ectopic expression of XPNPEP3 promoted tumorigenic properties in CRC cells. Immunohistochemistry on a CRC tissue microarray revealed significant correlation between β-catenin nuclear localization and XPNPEP3 levels. More importantly, XPNPEP3 expression was upregulated compared to normal samples in published expression datasets from several cancers including CRC. Finally, XPNPEP3 expression correlated with poor survival in many cancers. Our results therefore suggest XPNPEP3 to be a transcriptional target of Wnt/β-catenin pathway with particular significance for CRC

Item Type:	Article
Depositing User:	Users 2 not found.
Date Deposited:	03 Feb 2018 12:36
Last Modified:	17 Apr 2018 19:20
URI:	http://cdfd.sciencecentral.in/id/eprint/822

Actions (login required)

View Item